drugset / Trial / NCT05102448

Comparison of Tofacitinib and Methotrexate in Takayasu's Arteritis

NCT05102448

Phase 4 Recruiting 76 enrolled Shanghai Zhongshan Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this study is to evaluate and compare the efficacy and safety of tofacitinib and methotrexate based on prednisone therapy in patients with Takayasu arteritis

Timeline

Start
2021-11-01
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methotrexate Small molecule 15 mg Oral
Subject Tofacitinib Small molecule 5 mg Oral

Indications